Comparing Immune Responses to Topical Imiquimod
Condition(s):Actinic KeratosesLast Updated:July 12, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Actinic KeratosesLast Updated:July 12, 2022Active, not recruiting
Condition(s):KeloidLast Updated:November 19, 2020Terminated
Condition(s):Intraepithelial Neoplasia, CervicalLast Updated:May 3, 2021Unknown status
Condition(s):Oral CancerLast Updated:March 8, 2024Active, not recruiting
Condition(s):Cervical High Grade Squamous Intraepithelial Lesion; Cervical Intraepithelial Neoplasia Grade 2/3; CIN 2/3; Cervical Intraepithelial NeoplasiaLast Updated:September 11, 2023Recruiting
Condition(s):MelanomaLast Updated:December 16, 2016Completed
Condition(s):Port Wine StainsLast Updated:March 22, 2018Terminated
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:June 27, 2017Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:August 15, 2018Terminated
Condition(s):Superficial Basal Cell CarcinomaLast Updated:August 10, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.